Your browser doesn't support javascript.
loading
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Geyer, Charles E; Bandos, Hanna; Rastogi, Priya; Jacobs, Samuel A; Robidoux, André; Fehrenbacher, Louis; Ward, Patrick J; Polikoff, Jonathan; Brufsky, Adam M; Provencher, Louise; Paterson, Alexander H G; Hamm, John T; Carolla, Robert L; Baez-Diaz, Luis; Julian, Thomas B; Swain, Sandra M; Mamounas, Eleftherios P; Wolmark, Norman.
Afiliación
  • Geyer CE; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA. charles.geyer@nsabp.org.
  • Bandos H; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. charles.geyer@nsabp.org.
  • Rastogi P; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Jacobs SA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Robidoux A; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Fehrenbacher L; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Ward PJ; Department of Oncology, Magee Womens Hospital, Pittsburgh, PA, USA.
  • Polikoff J; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Brufsky AM; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Provencher L; Department of Surgery, Breast Cancer Research Group (GRCS), Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.
  • Paterson AHG; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Hamm JT; Kaiser Permenente Northern California, Vallejo, CA, USA.
  • Carolla RL; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Baez-Diaz L; Department of Medical Oncology, Onoclogy/Hematology Care Clinical Trials, Cincinnati, OH, USA.
  • Julian TB; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Swain SM; Department of Research and Evaluation - Clinical Trials -Oncology, Kaiser Permanente Southern California, San Diego, CA, USA.
  • Mamounas EP; NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
  • Wolmark N; Department of Oncology, Magee Womens Hospital, Pittsburgh, PA, USA.
Breast Cancer Res Treat ; 193(3): 565, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35507135
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos